Interacting Drugs |
Butalbital compound and codeine vs CYP1A2 Inhibitors (Moderate) |
Security Level |
 |
Mechanism |
CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates. |
Management |
Monitor therapy |
Butalbital compound and codeine vs CYP1A2 Inhibitors (Moderate)
Post Review about Butalbital compound and codeine vs CYP1A2 Inhibitors (Moderate) Click here to cancel reply.
Other Interactions of Butalbital compound and codeine
Other Interactions of CYP1A2 Inhibitors (Moderate)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.